The global diabetes treatment market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes, rising awareness about the disease and its complications, and technological advancements in the field of diabetes treatment.
Insulin segment accounted for the largest share in the global diabetes treatment market in 2017. Insulin segment is expected to continue its dominance throughout the forecast period due to its wide range of applications and benefits over other types of drugs. Oral hypoglycaemic drugs segment accounted for second-largest share in 2017 due to their low cost and easy availability as compared with insulin injections. No-insulin injectable drugs are expected to witness fastest growth during forecast period owing to their high efficacy rates and lower side effects as compared with oral hypoglycaemic drugs or insulin injections.
Some Of The Growth Factors Of This Market:
- In addition, technological advancements in diabetes treatment are also contributing to its growth as they help improve patient outcomes and reduce costs associated with managing the disease.
- For instance, insulin pumps have been developed that can be programmed for different types of insulin delivery patterns and can be used by patients who have type 1 or type 2 diabetes mellitus (T1DM or T2DM). These pumps provide more flexibility than traditional injections for managing blood sugar levels and are less painful than injections as well as being more convenient for patients who need multiple daily doses of insulin therapy .
Industry Growth Insights published a new data on “Diabetes Treatment Market”. The research report is titled “Diabetes Treatment Market research by Types (Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs), By Applications (Hospital, Personal Use, Clinic), By Players/Companies Novo Nordisk, Bayer, Teva Pharmaceuticals Pvt Ltd., Merck?Company Inc., Medtronic Inc., Johnson?Johnson, Home Diagnostics Inc., Amylin Pharmaceuticals Inc., Abbott Laboratories”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diabetes Treatment Market Research Report
By Type
Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs
By Application
Hospital, Personal Use, Clinic
By Companies
Novo Nordisk, Bayer, Teva Pharmaceuticals Pvt Ltd., Merck?Company Inc., Medtronic Inc., Johnson?Johnson, Home Diagnostics Inc., Amylin Pharmaceuticals Inc., Abbott Laboratories
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
245
Number of Tables & Figures
172
Customization Available
Yes, the report can be customized as per your need.
Global Diabetes Treatment Market Report Segments:
The global Diabetes Treatment market is segmented on the basis of:
Types
Insulin, Oral Hypoglycaemic Drugs, Non-Insulin Injectable Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Personal Use, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Novo Nordisk
- Bayer
- Teva Pharmaceuticals Pvt Ltd.
- Merck?Company Inc.
- Medtronic Inc.
- Johnson?Johnson
- Home Diagnostics Inc.
- Amylin Pharmaceuticals Inc.
- Abbott Laboratories
Highlights of The Diabetes Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin
- Oral Hypoglycaemic Drugs
- Non-Insulin Injectable Drugs
- By Application:
- Hospital
- Personal Use
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diabetes Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diabetes treatment typically includes diet and exercise, medication, and surgery.
Some of the key players operating in the diabetes treatment market are Novo Nordisk, Bayer, Teva Pharmaceuticals Pvt Ltd., Merck?Company Inc., Medtronic Inc., Johnson?Johnson, Home Diagnostics Inc., Amylin Pharmaceuticals Inc., Abbott Laboratories.
The diabetes treatment market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diabetes Treatment Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diabetes Treatment Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diabetes Treatment Market - Supply Chain
4.5. Global Diabetes Treatment Market Forecast
4.5.1. Diabetes Treatment Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diabetes Treatment Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diabetes Treatment Market Absolute $ Opportunity
5. Global Diabetes Treatment Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diabetes Treatment Market Size and Volume Forecast by Type
5.3.1. Insulin
5.3.2. Oral Hypoglycaemic Drugs
5.3.3. Non-Insulin Injectable Drugs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diabetes Treatment Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diabetes Treatment Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Personal Use
6.3.3. Clinic
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diabetes Treatment Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diabetes Treatment Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diabetes Treatment Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diabetes Treatment Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diabetes Treatment Demand Share Forecast, 2019-2026
9. North America Diabetes Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diabetes Treatment Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diabetes Treatment Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Personal Use
9.4.3. Clinic
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diabetes Treatment Market Size and Volume Forecast by Type
9.7.1. Insulin
9.7.2. Oral Hypoglycaemic Drugs
9.7.3. Non-Insulin Injectable Drugs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diabetes Treatment Demand Share Forecast, 2019-2026
10. Latin America Diabetes Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diabetes Treatment Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diabetes Treatment Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Personal Use
10.4.3. Clinic
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diabetes Treatment Market Size and Volume Forecast by Type
10.7.1. Insulin
10.7.2. Oral Hypoglycaemic Drugs
10.7.3. Non-Insulin Injectable Drugs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diabetes Treatment Demand Share Forecast, 2019-2026
11. Europe Diabetes Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diabetes Treatment Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diabetes Treatment Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Personal Use
11.4.3. Clinic
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diabetes Treatment Market Size and Volume Forecast by Type
11.7.1. Insulin
11.7.2. Oral Hypoglycaemic Drugs
11.7.3. Non-Insulin Injectable Drugs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diabetes Treatment Demand Share, 2019-2026
12. Asia Pacific Diabetes Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Personal Use
12.4.3. Clinic
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diabetes Treatment Market Size and Volume Forecast by Type
12.7.1. Insulin
12.7.2. Oral Hypoglycaemic Drugs
12.7.3. Non-Insulin Injectable Drugs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diabetes Treatment Demand Share, 2019-2026
13. Middle East & Africa Diabetes Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Personal Use
13.4.3. Clinic
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diabetes Treatment Market Size and Volume Forecast by Type
13.7.1. Insulin
13.7.2. Oral Hypoglycaemic Drugs
13.7.3. Non-Insulin Injectable Drugs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diabetes Treatment Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diabetes Treatment Market: Market Share Analysis
14.2. Diabetes Treatment Distributors and Customers
14.3. Diabetes Treatment Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Novo Nordisk
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bayer
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Teva Pharmaceuticals Pvt Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Merck?Company Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Johnson?Johnson
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Home Diagnostics Inc.
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Amylin Pharmaceuticals Inc.
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Abbott Laboratories
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
